Literature DB >> 22218895

Using 32-cell stage Xenopus embryos to probe PCP signaling.

Hyun-Shik Lee1, Sergei Y Sokol, Sally A Moody, Ira O Daar.   

Abstract

Use of loss-of function (via antisense Morpholino oligonucleotides (MOs)) or over-expression of proteins in epithelial cells during early embryogenesis of Xenopus embryos, can be a powerful tool to understand how signaling molecules can affect developmental events. The techniques described here are useful for examining the roles of proteins in cell-cell adhesion, and planar cell polarity (PCP) signaling in cell movement. We describe how to target specific regions within the embryos by injecting an RNA encoding a tracer molecule along with RNA encoding your protein of interest or an antisense MO to knock-down a particular protein within a specific blastomere of the embryo. Effects on cell-cell adhesion, cell movement, and endogenous or exogenous protein localization can be assessed at later stages in specific targeted tissues using fluorescent microscopy and immunolocalization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22218895      PMCID: PMC4461027          DOI: 10.1007/978-1-61779-510-7_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  Morphogenetic movements underlying eye field formation require interactions between the FGF and ephrinB1 signaling pathways.

Authors:  Kathryn B Moore; Kathleen Mood; Ira O Daar; Sally A Moody
Journal:  Dev Cell       Date:  2004-01       Impact factor: 12.270

Review 2.  Polarity of epithelial and neuronal cells.

Authors:  E Rodriguez-Boulan; S K Powell
Journal:  Annu Rev Cell Biol       Date:  1992

Review 3.  Planar cell polarity signaling: from fly development to human disease.

Authors:  Matias Simons; Marek Mlodzik
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

4.  Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway.

Authors:  Hyun-Shik Lee; Yong-Sik Bong; Kathryn B Moore; Kathleen Soria; Sally A Moody; Ira O Daar
Journal:  Nat Cell Biol       Date:  2005-12-18       Impact factor: 28.824

5.  A dual-pathway ultrastructural model for the tight junction of rat proximal tubule epithelium.

Authors:  Peng Guo; Alan M Weinstein; Sheldon Weinbaum
Journal:  Am J Physiol Renal Physiol       Date:  2003-04-01

6.  Cell polarity and cancer--cell and tissue polarity as a non-canonical tumor suppressor.

Authors:  Minhui Lee; Valeri Vasioukhin
Journal:  J Cell Sci       Date:  2008-04-15       Impact factor: 5.285

7.  Fates of the blastomeres of the 32-cell-stage Xenopus embryo.

Authors:  S A Moody
Journal:  Dev Biol       Date:  1987-08       Impact factor: 3.582

8.  EphrinB1 controls cell-cell junctions through the Par polarity complex.

Authors:  Hyun-Shik Lee; Tagvor G Nishanian; Kathleen Mood; Yong-Sik Bong; Ira O Daar
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

9.  Fibroblast growth factor receptor-induced phosphorylation of ephrinB1 modulates its interaction with Dishevelled.

Authors:  Hyun-Shik Lee; Kathleen Mood; Gopala Battu; Yon Ju Ji; Arvinder Singh; Ira O Daar
Journal:  Mol Biol Cell       Date:  2008-11-12       Impact factor: 4.138

10.  Development of tight junctions de novo in the mouse early embryo: control of assembly of the tight junction-specific protein, ZO-1.

Authors:  T P Fleming; J McConnell; M H Johnson; B R Stevenson
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

View more
  2 in total

1.  High-Sensitivity Mass Spectrometry for Probing Gene Translation in Single Embryonic Cells in the Early Frog (Xenopus) Embryo.

Authors:  Camille Lombard-Banek; Sally A Moody; Peter Nemes
Journal:  Front Cell Dev Biol       Date:  2016-10-05

2.  GPCR-independent activation of G proteins promotes apical cell constriction in vivo.

Authors:  Arthur Marivin; Veronika Morozova; Isha Walawalkar; Anthony Leyme; Dmitry A Kretov; Daniel Cifuentes; Isabel Dominguez; Mikel Garcia-Marcos
Journal:  J Cell Biol       Date:  2019-04-04       Impact factor: 10.539

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.